Anne Lesage is Chief Early Development at Pharvaris N.V. (PHVS). They have made 1 open-market trade across 1 company since 2026, most recently 2026-09-17.
CIK 0001973705
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PHVS | 73,969 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-21 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHVS | SELL | 2026-09-17 | 2026-09-21 | $38.27 | $765K | -12.9% | — | — |
| PHVS | SELL · 10b5-1 | 2026-09-10 | 2026-09-14 | $38.30 | $1.1M | -15.4% | -23.1% | — |
| PHVS | SELL · 10b5-1 | 2026-06-29 | 2026-07-01 | $35.39 | $2.7M | +0.6% | -4.6% | -7.2% |
| PHVS | SELL · 10b5-1 | 2026-06-25 | 2026-06-29 | $35.12 | $162K | +1.9% | -5.3% | -7.5% |
| PHVS | SELL · 10b5-1 | 2026-04-29 | 2026-05-01 | $30.23 | $1.5M | +11.4% | -1.5% | +14.5% |
| PHVS | SELL · 10b5-1 | 2026-04-22 | 2026-04-24 | $30.05 | $439K | +5.4% | +4.6% | +16.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.